Company
Headquarters: Shenzhen, China
Employees: 1,511
CN¥21.67 Billion
CNY as of Jan. 1, 2023
US$3.14 Billion
Company | Market Cap (USD) |
---|---|
![]() |
$191.43 B |
![]() |
$103.38 B |
![]() |
$92.52 B |
![]() |
$65.90 B |
![]() |
$56.23 B |
Company | Market Cap (USD) |
---|---|
![]() |
$495.37 B |
![]() |
$461.85 B |
![]() |
$347.61 B |
![]() |
$304.61 B |
![]() |
$287.63 B |
APT Medical Inc. engages in the research and development, manufacture, and sale of invasive interventional medical devices for cardiovascular and cerebrovascular diseases worldwide. The company offers electrophysiological catheter delivery systems, as well as radiofrequency ablation and mapping catheters; and vascular intervention products, such as diagnostic and treatment products, and intervention accessories. It also provides OEM/ODM services to catheter and metal products, as well as accessories. The company was founded in 2002 and is headquartered in Shenzhen, China.
APT Medical, Inc. has the following listings and related stock indices.
Stock: SSE: 688617